I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Atasoy, Ajlan
27
results:
Search for persons
X
Format
Online (27)
Mediatypes
Articles (Online) (11)
Bookchapter (Online) (1)
OpenAccess-fulltext (15)
Sorted by: Relevance
Sorted by: Year
?
1
Postoperative Chemotherapy Use and Outcomes From ADAURA: Os..:
Wu, Yi-Long
;
John, Thomas
;
Grohe, Christian
...
Journal of Thoracic Oncology. 17 (2022) 3 - p. 423-433 , 2022
Link:
https://doi.org/10.1016/..
?
2
A Plain Language Summary of Results From the ADAURA Study: ..:
Wu, Yi-Long
;
Tsuboi, Masahiro
;
John, Thomas
...
Future Oncology. 17 (2021) 35 - p. 4827-4835 , 2021
Link:
https://doi.org/10.2217/..
?
3
Improving Clinical Trial Design in Gastrointestinal Oncolog:
, In:
Textbook of Gastrointestinal Oncology
,
Atasoy, Ajlan
;
Mauer, Murielle
- p. 493-507 , 2019
Link:
https://doi.org/10.1007/..
?
4
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously ..:
Morse, Michael A.
;
Overman, Michael J.
;
Hartman, Leighanne
...
The Oncologist. 24 (2019) 11 - p. 1453-1461 , 2019
Link:
https://doi.org/10.1634/..
?
5
Phase II Study of Irinotecan Plus Panitumumab as Second-Lin..:
Yoon, Harry
;
Karapetyan, Lilit
;
Choudhary, Anita
...
The Oncologist. 23 (2018) 9 - p. 1004-e102 , 2018
Link:
https://doi.org/10.1634/..
?
6
Lapatinib with ECF/X in the first-line treatment of metasta..:
the EORTC Gastrointestinal Tract Cancer Group
;
Moehler, Markus
;
Schad, Arno
...
Cancer Chemotherapy and Pharmacology. 82 (2018) 4 - p. 733-739 , 2018
Link:
https://doi.org/10.1007/..
?
7
Core Clinical Data Elements for Cancer Genomic Repositories..:
Conley, Robert B.
;
Dickson, Dane
;
Zenklusen, Jean Claude
...
Cell. 171 (2017) 5 - p. 982-986 , 2017
Link:
https://doi.org/10.1016/..
?
8
Impact of Oncotype DX Recurrence Score on Treatment Decisio..:
Ozmen, Vahit
;
Atasoy, Ajlan
;
Gokmen, Erhan
...
Cureus. , 2016
Link:
https://doi.org/10.7759/..
?
9
Hypersensitivity and Tumor Lysis Syndrome Associated with C..:
Cihan, Sener
;
Atasoy, Ajlan
;
Yildirim, Yasar
..
Tumori Journal. 101 (2015) 2 - p. e40-e45 , 2015
Link:
https://doi.org/10.5301/..
?
10
Prognostic value of receptor status change following neoadj..:
Ozmen, Vahit
;
Atasoy, Ajlan
;
Bozdogan, Atilla
...
Cancer Treatment Communications. 4 (2015) - p. 89-95 , 2015
Link:
https://doi.org/10.1016/..
?
11
Barrett's esophagus and animal models:
Macke, Ryan A.
;
Nason, Katie S.
;
Mukaisho, Ken‐ichi
...
Annals of the New York Academy of Sciences. 1232 (2011) 1 - p. 392-400 , 2011
Link:
https://doi.org/10.1111/..
?
12
Barrett's esophagus: treatments of adenocarcinomas I:
Komanduri, Srinadh
;
Deprez, Pierre H.
;
Atasoy, Ajlan
...
Annals of the New York Academy of Sciences. 1232 (2011) 1 - p. 248-264 , 2011
Link:
https://doi.org/10.1111/..
?
13
Impact Of Oncotype Dx Recurrence Score On Treatment Decisio..:
Ozmen, Vahit
;
Atasoy, Ajlan
;
Gokmen, Erhan
...
10.7759/cureus.522. , 2019
Link:
http://hdl.handle.net/11..
?
14
Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously ..:
Morse, Michael A
;
Overman, Michael J
;
Hartman, Leighanne
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853093/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
15
Phase II Study of Irinotecan Plus Panitumumab as Second‐Lin..:
Yoon, Harry
;
Karapetyan, Lilit
;
Choudhary, Anita
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192615/. , 2018
Link:
http://www.ncbi.nlm.nih...
1-15